Although the human lifespan has increased over recent decades, the human health-span has been unable to keep pace. While we are living longer due to scientific advancements, the number of years we spend without age-related diseases has not increased proportionately.
Lifestyle interventions often recommended too late in life tend not to be sufficient to prevent, halt, or reverse age-related decline. Research scientists are increasingly focusing on potential pharmaceutical interventions to combat the negative aspects of aging. One pathway of exploration aims to repurpose existing medications for geroprotection and is proving remarkably successful in early trials.
We are pleased to announce that the A4M October Symposium in Charleston, South Carolina, was a resounding success. Held at the Charleston Place hotel between October 27-29, this three-day event drew in several hundreds of attendees from across the nation for an exciting weekend of innovative, immersive education. Nearly 40 educational sessions led by 18 renowned speakers engaged event participants with the latest research, expert insights, live demonstrations, and hands-on training. Covering intravenous (IV) and chelation therapy, pellet therapy, and longevity medicine, three different workshops delivered impactful takeaways, protocols, and practical strategies to implement directly into clinical practice.
In case you missed it or would like to revisit some of your favorite moments, we have compiled a selection of Symposium highlights in the recap below.
Cognitive performance is a critical capability that allows individuals to function accordingly in their everyday lives; it provides humans with the capacity for sustenance and self-preservation and the free will to engage in activities of their choice. However, many researchers have posed a question regarding the sustainability of the human body’s cognitive performance, particularly because cognition may not be an all-enduring ability and is subject to different levels of degradation.
Several studies have proposed this concept, and research shows that several factors could affect a person’s cognitive ability, along with the discovery that multiple types of cognition correlate to specific functionality in the human body.
After several assessments of this proposed thesis, oxidative stress was considered one of the most significant factors correlated to a decrease in cognitive performance. This type of degradation is associated with the inherent decline of the body – aging.